Published: 2018-09-22

Clinical profile of rheumatic patients with infectious complications

Pandharinath S. Gawali, Umesh P. Gawali


Background: The objective of the present research was to study clinical profile of rheumatic patients having infections including correlation of infection with different parameters and DMARDS and to study incidence pattern of various infections.

Methods: All patients of various Rheumatic diseases with infections who fulfil inclusion criteria who were enrolled in this study. Duration of study was six months. A total of 300 patients where studied out of which 50 were cases and the rest were control.

Results: Incidence of infection was high in extremes of age. Overall incidence of infection was slightly higher in females. Infection rate was 16.66%. Incidence of infection was highest among vasculitis group. Kidney was the most common organ involved. Incidence of infection was more in patients having anemia and leukopenia. Tuberculosis was the most common infection found in Rheumatic patients.

Conclusions: Infection was more common at extremes of age and more common in females. SLE was most common disease encountered while kidney was most common organ to get involve in disease process. Patients with anemia and leukopenia had statistically significant incidence of infections. Tuberculosis is most common infection encountered in Indian rheumatic patients.


Clinical profile, CYC cyclophosphamide, DMARD’s Disease modifying antirheumating drugs, Infectious complications, Rheumatic patients

Full Text:



Petri M, Genovese M. Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins Lupus Cohort. J Rheumatol. 1992 Oct;19(10):1559-65.

Prakash UB. Respiratory complications in mixed connective tissue disease. Clin Chest Med. 1998 Dec 1;19(4):733-46.

Rosner S, Ginzler EM, Diamond HS, Weiner M, Schlesinger M, Fries JF, et al. A multicenter study of outcome in systemic lupus erythematosus. ii. Arthritis and rheumatism. J Am Coll Rheumatol. 1982 Jun;25(6):612-7.

Sayarlioglu M, Inanc M, Kamali S, Cefle A, Karaman O, Gul A, et al. Tuberculosis in Turkish patients with systemic lupus erythematosus: increased frequency of extrapulmonary localization. Lupus. 2004 Apr;13(4):274-8.

Garred P, Voss A, Madsen HO, Junker P. Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients. Genes and immunity. 2001 Dec;2(8):442.

Bouza E, Moya JG, Muñoz P. Infections in systemic lupus erythematosus and rheumatoid arthritis. Infect Dis Clin. 2001 Jun 1;15(2):335-61.

Duffy KN, Duffy CM, Gladman DD. Infection and disease activity in systemic lupus erythematosus: a review of hospitalized patients. J Rheumatol. 1991 Aug;18(8):1180-4.

Jindal B, Joshi K, Radotra BD, Banerjee AK. Fatal complications of systemic lupus erythematosus-an autopsy study from north India. Indian J Pathol Microbiol. 2000 Jul;43(3):311-7.

Shyam C, Malaviya AN. Infection-related morbidity in systemic lupus erythematosus: a clinico-epidemiological study from northern India. Rheumatol Inte. 1996 Jan 1;16(1):1-3.

Mohan VP, Scanga CA, Yu K, Scott HM, Tanaka KE, Tsang E, Tsai MC, Flynn JL, Chan J. Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology. Infect Immun. 2001 Mar 1;69(3):1847-55.